Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus
AIM: To assess tumour regression grade (TRG) and lymph node downstaging to help define patients who benefit from neoadjuvant chemotherapy. METHODS: Two hundred and eighteen consecutive patients with adenocarcinoma of the esophagus or gastro-esophageal junction treated with surgery alone or neoadjuv...
Main Authors: | Noble, Fergus (Author), Nolan, Luke (Author), Bateman, Adrian C. (Author), Byrne, James (Author), Kelly, Jamie (Author), Bailey, Ian (Author), Sharland, Donna (Author), Rees, Charlotte (Author), Iveson, T. (Author), Underwood, T.J (Author), Bateman, Andrew R. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
2013-12-28.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
The effect of triplet platinum based neo-adjuvant chemotherapy on peri-operative outcome after oesophagectomy
by: Underwood, Tim, et al.
Published: (2010) -
The relevance of the Siewert classification in the era of multimodal therapy for adenocarcinoma of the gastro-oesophageal junction
by: Curtis, Nathan J., et al.
Published: (2014) -
Perioperative chemotherapy versus neoadjuvant chemoradiation for patients with adenocarcinoma of the distal esophagus in Austria: a retrospective analysis
by: Oliver O. Koch, et al.
Published: (2019-08-01) -
Barrett's Esophagus and Adenocarcinoma
by: Z.W. Li, et al.
Published: (1988-01-01) -
Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS)
by: Richel DJ, et al.
Published: (2008-11-01)